Find your next paid study

University of RochesterNCT07393529

Actual pay is set by the research site.

Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression: Toward Predictors of Treatment Response and Clinical Course

Despite the prevalence and significant public health concern over depression among adolescents, up to 40% of depressed adolescents do not respond to first-line…

Depression in Adolescence

University of California, Los AngelesNCT05329441

Actual pay is set by the research site.

Myeloid Leukemia, Philadelphia Positive

A Multi-center, Open-label Study to Determine the Dose and Safety of Oral Asciminib in Pediatric Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP), Previously Treated With One or More Tyrosine Kinase Inhibitors

The aim of this study is to support development of asciminib in the pediatric population (1 to \<18 years) previously treated with one or more TKIs. Full extra…

Novartis PharmaceuticalsNCT04925479

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

Optimal Treatment by Invoking Biologic Clusters in Renal Cell Carcinoma (OPTIC RCC)

This phase II trial tests whether using genetic testing of tumor tissue to select the optimal treatment regimen works in treating patients with clear cell rena…

Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more

Vanderbilt-Ingram Cancer CenterNCT05361720

~$75 – $2,000

Actual pay is set by the research site.

Pediatric Normative Markerless Movement Analysis Data Collection Project

The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients exp…

Pediatric ALLAdolescent

MultiCare Health System Research InstituteNCT06249880

Actual pay is set by the research site.

An Early Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of PEEL-224 in Patients With Advanced Solid Tumors

This is a first-in-human, dose escalation, repeat-dose, multi-center, open-label study evaluating safety, tolerability, PK, and preliminary antitumor activity …

Advanced Solid Tumor

Peel Therapeutics IncNCT05329103

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

An Open-Label Phase II Study of ILKN421H in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

This is a multicenter, open-label, phase II study to evaluate the safety, tolerability, clinical activity, and pharmacokinetics of ILKN421H in combination with…

Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

iLeukon Therapeutics, Inc.NCT07452224

~$75 – $2,800

Actual pay is set by the research site.

DUH Innovation Units

This quality improvement initiative aims to evaluate the implementation, utilization, and impact of virtual care technologies and workflows being implemented a…

Falls InjuryReadmission RatesCLABSI - Central Line Associated Bloodstream Infection+6 more

Duke UniversityNCT07406074

Actual pay is set by the research site.

Observational

Dose Escalated CT-Based Adaptive Stereotactic Body Radiation Therapy Among Patients With Intermediate- and Favorable High- Risk Prostate Cancer (DE-CART)

The goal of this clinical trial is to evaluate if adaptive stereotactic body radiation therapy (SBRT) is a safe and effective way to treat prostate cancer in a…

Prostate Cancer (Adenocarcinoma)

Fox Chase Cancer CenterNCT07219303

Actual pay is set by the research site.

Lung AdenocarcinomaStage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8Stage IA2 Lung Cancer AJCC v8+2 more

An Open-Label Safety and Tolerability Pilot Study of Dapagliflozin in Stage IA Lung Adenocarcinoma

This early phase I trial tests the safety and side effects of dapagliflozin given prior to surgery in patients with stage IA lung adenocarcinoma. Dapagliflozin…

Jonsson Comprehensive Cancer CenterNCT07235280

~$150 – $3,000

Actual pay is set by the research site.

Vulvar AdenocarcinomaPDAC - Pancreatic Ductal AdenocarcinomaGastric Adenocarcinoma+6 more

A Phase 1, Open Label, Dose-Escalation and Expansion Study to Evaluate Safety, Pharmacokinetics and Initial Therapeutic Activity of AVA6103, a Novel FAP-activated Exatecan Administered Intravenously in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

This is a first-in-human (FIH), Phase 1 open-label, multicenter dose escalation study investigating AVA6103 monotherapy administered intravenously in patients …

~$150 – $4,200

Actual pay is set by the research site.

Avacta Life Sciences Ltd

Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more

A Phase 1 Clinical Trial of 64Cu-DOTA A2 scFv-Fc2 DM (64Cu-DOTA-A2DM) Positron Emission Tomography in Patients With Metastatic PSCA-Expressing Pancreatic Cancer

This clinical trial tests the safety, side effects, best dose and feasibility of using 64Cu-DOTA A2 scFv-Fc2 DM with positron emission tomography for the imagi…